1. Home
  2. RCKT vs BYON Comparison

RCKT vs BYON Comparison

Compare RCKT & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • BYON
  • Stock Information
  • Founded
  • RCKT 1999
  • BYON 1997
  • Country
  • RCKT United States
  • BYON United States
  • Employees
  • RCKT N/A
  • BYON N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • RCKT Health Care
  • BYON Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • BYON Nasdaq
  • Market Cap
  • RCKT 328.6M
  • BYON 556.8M
  • IPO Year
  • RCKT N/A
  • BYON N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • BYON $9.44
  • Analyst Decision
  • RCKT Buy
  • BYON Hold
  • Analyst Count
  • RCKT 13
  • BYON 8
  • Target Price
  • RCKT $12.96
  • BYON $10.33
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • BYON 2.6M
  • Earning Date
  • RCKT 08-07-2025
  • BYON 10-23-2025
  • Dividend Yield
  • RCKT N/A
  • BYON N/A
  • EPS Growth
  • RCKT N/A
  • BYON N/A
  • EPS
  • RCKT N/A
  • BYON N/A
  • Revenue
  • RCKT N/A
  • BYON $1,128,578,000.00
  • Revenue This Year
  • RCKT N/A
  • BYON N/A
  • Revenue Next Year
  • RCKT $108.43
  • BYON $11.56
  • P/E Ratio
  • RCKT N/A
  • BYON N/A
  • Revenue Growth
  • RCKT N/A
  • BYON N/A
  • 52 Week Low
  • RCKT $2.19
  • BYON $3.54
  • 52 Week High
  • RCKT $22.01
  • BYON $12.24
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • BYON 55.14
  • Support Level
  • RCKT $2.88
  • BYON $9.11
  • Resistance Level
  • RCKT $3.74
  • BYON $9.89
  • Average True Range (ATR)
  • RCKT 0.27
  • BYON 0.60
  • MACD
  • RCKT 0.02
  • BYON -0.00
  • Stochastic Oscillator
  • RCKT 35.43
  • BYON 72.04

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: